{
  "zip": "M5C 1P1",
  "sector": "Healthcare",
  "longBusinessSummary": "Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers novel cannabinoid-centric treatments for liver diseases, inflammatory diseases, and skin disorders. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and coronavirus disease; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocybin oral formulations for the treatment of depression, anxiety, etc.; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has a research collaboration agreement with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; and with North Carolina State University for the development of a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform. The company was incorporated in 2012 and is headquartered in Toronto, Canada.",
  "city": "Toronto",
  "phone": "888 901 0036",
  "state": "ON",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.revivethera.com",
  "maxAge": 1,
  "address1": "The Canadian Venture Building",
  "industry": "Drug Manufacturersâ€”Specialty & Generic",
  "address2": "82 Richmond Street East",
  "previousClose": 0.4922,
  "regularMarketOpen": 0.5,
  "twoHundredDayAverage": 0.5067619,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.5071,
  "navPrice": null,
  "averageDailyVolume10Day": 1852875,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.4922,
  "fiftyDayAverage": 0.5067619,
  "trailingAnnualDividendRate": null,
  "open": 0.5,
  "averageVolume10days": 1852875,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -0.050825,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.47093,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 1180890,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 114969840,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 3842661,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.47093,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 1180890,
  "fiftyTwoWeekHigh": 0.7,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.43,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.5071,
  "exchange": "PNK",
  "shortName": "REVIVE THERAPEUTICS LTD",
  "longName": "Revive Therapeutics Ltd.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "RVVTF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_243258400",
  "uuid": "0df7c848-3a31-346d-92bb-c942e324b0a7",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 236791008,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.007,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1593475200,
  "heldPercentInstitutions": 0.00116,
  "netIncomeToCommon": null,
  "trailingEps": -0.022,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 69.928566,
  "heldPercentInsiders": 0.09564,
  "nextFiscalYearEnd": 1656547200,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 229116216,
  "enterpriseValue": 116548336,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.5,
  "logo_url": "https://logo.clearbit.com/revivethera.com"
}